Tesamorelin 1 mg Injection
RxNorm 2168763
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2168763 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tesamorelin 1 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Tesamorelin 1 mg Injection
(Atom ID: 11417523)
FN
Full form of descriptor (FN):
Product containing precisely tesamorelin (as tesamorelin acetate) 1 mg/1 vial powder for conventional release solution for injection (clinical drug)
(Atom ID: 12727538)
SY
Synonym (SY):
Tesamorelin (as tesamorelin acetate) 1 mg Injection
(Atom ID: 11449847)
PT
Designated preferred name (PT):
Tesamorelin (as tesamorelin acetate) 1 mg powder for solution for injection vial
(Atom ID: 12727936)
PSN
Prescribable Name (PSN):
Tesamorelin 1 mg Injection
(Atom ID: 11417528)
Patient Education
Tesamorelin Injection
Tesamorelin injection is used to decrease the amount of extra fat in the stomach area in adults with human immunodeficiency virus (HIV) who have lipodystrophy (increased body fat in certain areas of the body). Tesamorelin injection is not used to help with weight loss. Tesamorelin injection is in a class of medications called human growth hormone-releasing factor (GRF) analogs. It works by increasing the production of a certain natural substance that can decrease the amount of body fat.
[Learn More]
* Please review the disclaimer below.